Steven Gillis

Current Research Topics

• Molecular and tumor immunology

Professional Activities

Academic positions

• Tuck School, 2012–present
• Adjunct Professor of Community and Family Medicine, Dartmouth Medical School, 2009–present
• Adjunct Professor of Business Administration, Tuck School, 2011
• Adjunct Professor, 1990–98, Adjunct Associate Professor, 1983–90, Assistant Professor, 1980–83, University of Washington

Nonacademic positions

• Managing Director, ARCH Venture Partners, 2005–present
• Founder and Director, Corixa Corporation, 1994–2005
• Founder and Director, Immunex Corporation, 1981–98

Board memberships

• Director, Accelerator Corporation, Allozyne, VBI Vaccines, Groove Pharmaceuticals, Acylin Corporation, PhaseRx, Pulmatrix, VentiRx Pharmaceuticals, Theraclone Sciences, Lycera, and VLST Corporation
• Board of Overseers, Dartmouth Medical School
• Board of Advisors, Norris Cotton Cancer Center
• Discovery Investment Board, GlaxoSmithKline
• Board of Advisors, The W Fund

Editorial positions

• Editor-in-Chief, Lymphokine Research, 1982–83
• Editor, Biotechnology Therapeutics, 1989–93
• Associate Editor, Journal of Cellular and Molecular Immunology, 1984–94
• Lymphokine Research, 1983–85, Journal of Biological Response Modifiers, 1982–89, Journal of Immunology, 1980–83
• Editorial Board, Therapeutic Immunology, 1992–99, Journal of Clinical Immunology, 1990–2000, Journal of Immunotherapy, 1989–2001, Molecular Biotherapy, 1988–92, Journal of Cellular Immunology, 1984–94
• Editorial Advisory Board, Cytokine, 1990–present

Awards

• International Immunopharmacology Award, 1983
• Conant-Harrington Prize for Outstanding Research in Biology, 1976